Global Interventional Tumor Ablation Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Interventional Tumor Ablation Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Interventional tumor ablation is a minimally invasive medical procedure performed to treat certain types of tumors. It involves the use of various techniques to destroy or eliminate tumors without the need for open surgery. The goal of interventional tumor ablation is to selectively target and destroy tumor cells while minimizing damage to surrounding healthy tissues.
Interventional Tumor Ablation report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Interventional Tumor Ablation market is projected to reach US$ 2940.8 million in 2033, increasing from US$ 1654.2 million in 2022, with the CAGR of 9.3% during the period of 2023 to 2033. Demand from Hospitals And Clinics and Outpatient Surgery Center are the major drivers for the industry.
There has been an increasing demand for minimally invasive treatment options for tumors. Interventional tumor ablation techniques, such as radiofrequency ablation, microwave ablation, cryoablation, and laser ablation, offer less invasive alternatives to traditional surgery. Patients often prefer these procedures due to their shorter recovery times, reduced complications, and the potential to preserve organ function.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Interventional Tumor Ablation market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Boston Scientific Corporation
Johnson & Johnson
Medtronic Plc
Varian Medical Systems
EDAP TMS S.A.
AngioDynamics
CASCINATION AG
Merit Medical Systems
STARmed
Segment by Type
Radiofrequency Ablation
Microwave Ablation
Cryoablation
Irreversible Electroporation Ablation
Hospitals And Clinics
Outpatient Surgery Center
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Interventional Tumor Ablation market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Interventional Tumor Ablation introduction, etc. Interventional Tumor Ablation Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Interventional Tumor Ablation market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Interventional Tumor Ablation report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Interventional Tumor Ablation market is projected to reach US$ 2940.8 million in 2033, increasing from US$ 1654.2 million in 2022, with the CAGR of 9.3% during the period of 2023 to 2033. Demand from Hospitals And Clinics and Outpatient Surgery Center are the major drivers for the industry.
There has been an increasing demand for minimally invasive treatment options for tumors. Interventional tumor ablation techniques, such as radiofrequency ablation, microwave ablation, cryoablation, and laser ablation, offer less invasive alternatives to traditional surgery. Patients often prefer these procedures due to their shorter recovery times, reduced complications, and the potential to preserve organ function.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Interventional Tumor Ablation market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Boston Scientific Corporation
Johnson & Johnson
Medtronic Plc
Varian Medical Systems
EDAP TMS S.A.
AngioDynamics
CASCINATION AG
Merit Medical Systems
STARmed
Segment by Type
Radiofrequency Ablation
Microwave Ablation
Cryoablation
Irreversible Electroporation Ablation
Segment by Application
Hospitals And Clinics
Outpatient Surgery Center
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Interventional Tumor Ablation market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Interventional Tumor Ablation introduction, etc. Interventional Tumor Ablation Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Interventional Tumor Ablation market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.